Vascular System

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

Vascular occlusion by neutrophil extracellular traps in COVID-19.

Platelet gene expression and function in patients with COVID-19.

Neutrophil extracellular traps and thrombosis in COVID-19.

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

COVID-19-associated coagulopathy: An exploration of mechanisms.

COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.

Immunothrombosis and thromboinflammation in host defense and disease.

Preventing the development of severe COVID-19 by modifying immunothrombosis.

Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage

The role of biomarkers in diagnosis of COVID-19 - A systematic review.

Biomarkers associated with COVID-19 disease progression.

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in Chi

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.

COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.

Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.

Single-Center Vascular Hub Experience after 7 weeks of COVID-19 Pandemic in Lombardy (Italy).

Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients

Prognostic value of C-reactive protein in patients with COVID-19.

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.

The role of peripheral blood eosinophil counts in COVID-19 patients.

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

Hematological findings and complications of COVID-19.

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.

Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.

Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study.

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suz

Morphologically abnormal neutrophil granulocytes in COVID-19 cases.

Vascular Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.

Morphological anomalies of circulating blood cells in COVID-19.

Tissue damage from neutrophil-induced oxidative stress in COVID-19.

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 20